deltatrials
Active Not Recruiting PHASE2 INTERVENTIONAL 2-arm NCT05681884

Safety and Efficacy of Faricimab in Patients With NPDR (MAGIC)

Faricimab for Retinal Non-Perfusion Associated With Non-Proliferative Diabetic Retinopathy: The MAGIC Phase 2, Multi-Center, Open-Label, Randomized Controlled Trial

Sponsor: Genentech, Inc.

Interventions Faricimab
Updated 9 times since 2023 Last updated: Jan 22, 2025 Started: May 16, 2023 Primary completion: Mar 20, 2026 Completion: Apr 13, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Non-Proliferative Diabetic Retinopathy, this trial is ongoing. The trial is conducted by Genentech, Inc. and has accumulated 9 data snapshots since 2023. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Feb 2023 – ~Mar 2023 · 28 days · monthly snapshotNot Yet Recruiting~Mar 2023 – ~Jul 2023 · 4 months · monthly snapshotNot Yet Recruiting~Jul 2023 – ~Sep 2023 · 2 months · monthly snapshotRecruiting~Sep 2023 – ~Nov 2023 · 2 months · monthly snapshotRecruiting~Nov 2023 – ~May 2024 · 6 months · monthly snapshotRecruiting~May 2024 – ~Jul 2024 · 2 months · monthly snapshotActive Not Recruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotActive Not Recruiting~Sep 2024 – ~Feb 2025 · 5 months · monthly snapshotActive Not Recruiting~Feb 2025 – present · 17 months · monthly snapshotActive Not Recruiting

Change History

9 versions recorded
  1. Feb 2025 — Present [monthly]

    Active Not Recruiting PHASE2

  2. Sep 2024 — Feb 2025 [monthly]

    Active Not Recruiting PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting PHASE2

  4. May 2024 — Jul 2024 [monthly]

    Active Not Recruiting PHASE2

    Status: RecruitingActive Not Recruiting

  5. Nov 2023 — May 2024 [monthly]

    Recruiting PHASE2

Show 4 earlier versions
  1. Sep 2023 — Nov 2023 [monthly]

    Recruiting PHASE2

  2. Jul 2023 — Sep 2023 [monthly]

    Recruiting PHASE2

    Status: Not Yet RecruitingRecruiting

  3. Mar 2023 — Jul 2023 [monthly]

    Not Yet Recruiting PHASE2

  4. Feb 2023 — Mar 2023 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Genentech, Inc.
  • Greater Houston Retina Research
Data source: Greater Houston Retina Research

For direct contact, visit the study record on ClinicalTrials.gov .